Cost-effectiveness of inhaled corticosteroids in chronic obstructive pulmonary disease [1] (multiple letters)

American Journal of Medicine

Volumn 117, Issue 8, 2004, Pages 618-619

  Lee, Todd A ^c   Weiss, Kevin B ^a   Sullivan, Sean D ^b   Sin, Don D ^d   Golmohammadi, Kamran ^e   Jacobs, Philip ^f  

^a NORTHWESTERN UNIVERSITY   (United States)

^b Washington ^*  (United States)

^c HINES VA HOSPITAL   (United States)

^d UNIVERSITY OF BRITISH COLUMBIA   (Canada)

^e INSTITUTE OF HEALTH ECONOMICS   (Canada)

^f UNIVERSITY OF ALBERTA   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

CORTICOSTEROID;

CHRONIC OBSTRUCTIVE LUNG DISEASE; CORTICOSTEROID THERAPY; COST BENEFIT ANALYSIS; COST EFFECTIVENESS ANALYSIS; COST OF ILLNESS; DISEASE SEVERITY; DRUG COST; DRUG RESPONSE; EVIDENCE BASED MEDICINE; HUMAN; LETTER; MORTALITY; PRIORITY JOURNAL; QUALITY OF LIFE; TREATMENT OUTCOME;

ADMINISTRATION, INHALATION; ADRENAL CORTEX HORMONES; COST-BENEFIT ANALYSIS; HUMANS; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; QUALITY-ADJUSTED LIFE YEARS;

EID: 4644339200     PISSN: 00029343     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.amjmed.2004.05.021     Document Type: Letter

References (7)

1. D.D. Sin, K. Golmohammadi, P. Jacobs Cost-effectiveness of inhaled corticosteroids for chronic obstructive pulmonary disease according to disease severity Am J Med. 116 2004 325 331
2. P.D. Scanlon, J.E. Connett, and L.A. Waller Smoking cessation and lung function in mild-to-moderate chronic obstructive pulmonary disease The Lung Health Study Am J Respir Crit Care Med 161 2000 381 390
3. D.M. Mannino, A.S. Buist, and T.L. Petty Lung function and mortality in the United States data from the First National Health and Nutrition Examination Survey follow up study Thorax 58 2003 388 393
4. A. Alsaeedi, D.D. Sin, F.A. McAlister The effects of inhaled corticosteroids in chronic obstructive pulmonary disease a systematic review of randomized placebo-controlled trials Am J Med 113 2002 59 65
5. P. Prescott-Clarke, P. Primatesta Health Survey for England 1996 1998 HMSO London, United Kingdom
6. E. Ståhl, A. Lindberg, and E. Rönmark The level of health-related quality of life in patients with COPD and its dependence on age, gender and disease severity Eur Respir J 18 suppl 33 2001 184S
7. N.R. Anthonisen, J.E. Connett, and J.P. Kiley Effects of smoking intervention and the use of inhaled anticholinergic bronchodilator on the rate of decline in FEV1 The Lung Health Study JAMA 272 1994 1497 1505